retatrutide and tesamorelin together Stacking & Retatrutide? A Pathologist Explains retatrutide tesamorelin ipamorelin CJC 1295,

Nervous system disorders Uncommon: Headache Not known: Convulsions*, Dizziness Heart disease Not known: Palpitations Vascular pathologies Uncommon: Hypertension, Hypotension Respiratory, thoracic and mediastinal pathologies Not known: Dyspnea Gastrointestinal disorders Common: Vomiting, Nausea, Diarrhea, Abdominal pain Uncommon: Dysgeusia, Dyspepsia, Dry mouth Skin and subcutaneous tissue disorders Uncommon: Abnormal skin odor ** Not known: Itching, Skin rash Musculoskeletal and connective tissue disorders Uncommon: Muscle spasms Not known: Myasthenia***, Muscle tension Systemic disorders and conditions related to the administration site Uncommon: Chest pain, Feeling abnormal, Pyrexia, Injection site reaction**** Diagnostic tests Uncommon: Increased blood pressure Very rare: Increased INR*****

Manufactured by Eli Lilly, it represents a novel class of therapy known as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist

While the principles regulating glucose-dependence in cancer cells have been extensively reviewed, we still do not fully understand how cancer cells use many of the metabolic strategies to contribute to core metabolic functions in the presence of nutrients different from glucose

J Biol Chem 280: 3225432261 Pollard MG, Travers KJ, Weissman JS (1998) Ero1p: a novel and ubiquitous protein with an essential role in oxidative protein folding in the endoplasmic reticulum

May your nerves stay calm, your skin stay comfortable, and your protocols stay well-informed.